Literature DB >> 14623355

Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction.

Huibert D Mansvelder1, Mischa De Rover, Daniel S McGehee, Arjen B Brussaard.   

Abstract

Nicotine reinforces smoking behaviour by activating nicotinic acetylcholine receptors in the midbrain dopaminergic reward centres. Upstream of the dopaminergic neurons nicotine induces long-term potentiation of the excitatory input to dopamine cells in the ventral tegmental area, and depresses inhibitory inputs. Both effects of nicotine were shown to last much longer than the nicotine exposure and together will activate the dopaminergic ventral tegmental area projection toward the nucleus accumbens. However, downstream of dopamine, effects of nicotine are also likely to occur. Cholinergic interneurons within the nucleus accumbens are important in the tonic control of the gamma-amino buteric acid (GABA) nucleus accumbens output neurons, which project back to the ventral tegmental area. The nicotinic acetylcholine receptors that mediate this control are likely to desensitise upon preexposure to the nicotine concentrations found in the blood of smokers. Thus, synaptic mechanisms both upstream and downstream of dopamine release are potentially important factors contributing to the etiology of nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623355     DOI: 10.1016/j.ejphar.2003.08.099

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  56 in total

Review 1.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

Review 2.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes.

Authors:  Laura E O'Dell; Luis A Natividad; Joseph A Pipkin; Francisco Roman; Ivan Torres; Jesus Jurado; Oscar V Torres; Theodore C Friedman; John M Tenayuca; Arbi Nazarian
Journal:  Addict Biol       Date:  2013-07-08       Impact factor: 4.280

Review 5.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

Review 6.  Glial-neuronal interactions--implications for plasticity and drug addiction.

Authors:  Sukumar Vijayaraghavan
Journal:  AAPS J       Date:  2009-02-24       Impact factor: 4.009

7.  Insulin modulates the strong reinforcing effects of nicotine and changes in insulin biomarkers in a rodent model of diabetes.

Authors:  Bryan Cruz; Rodolfo J Flores; Kevin P Uribe; Evangelina J Espinoza; Charles T Spencer; Katherine M Serafine; Arbi Nazarian; Laura E O'Dell
Journal:  Neuropsychopharmacology       Date:  2019-01-07       Impact factor: 7.853

Review 8.  Heterogeneity of reward mechanisms.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2009-12-12       Impact factor: 3.996

9.  The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury.

Authors:  Timothy C Durazzo; Linda Abadjian; Adam Kincaid; Tobias Bilovsky-Muniz; Lauren Boreta; Grant E Gauger
Journal:  J Neurotrauma       Date:  2013-06-06       Impact factor: 5.269

10.  Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro.

Authors:  Cameron H Good; Carl R Lupica
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.